Diagnostic Value of Autoantibodies against Ezrin in Esophageal Squamous Cell Carcinoma
Esophageal squamous cell carcinoma (ESCC), one of the most common malignancies worldwide, is a highly aggressive and homogeneous entity occurring in esophageal squamous epithelium, and a reliable noninvasive test for early detection is needed. A recent study showed that serum autoantibodies against...
Main Authors: | Lan Li, Ming Liu, Jian-Bang Lin, Xin-Bin Hong, Wen-Xia Chen, Hong Guo, Li-Yan Xu, Yi-Wei Xu, En-Min Li, Yu-Hui Peng |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2017-01-01
|
Series: | Disease Markers |
Online Access: | http://dx.doi.org/10.1155/2017/2534648 |
Similar Items
-
Serum Autoantibodies against STIP1 as a Potential Biomarker in the Diagnosis of Esophageal Squamous Cell Carcinoma
by: Yi-Wei Xu, et al.
Published: (2017-01-01) -
PPI Network Analysis of mRNA Expression Profile of Ezrin Knockdown in Esophageal Squamous Cell Carcinoma
by: Bingli Wu, et al.
Published: (2014-01-01) -
Prognostic relevance of Bmi-1 expression and autoantibodies in esophageal squamous cell carcinoma
by: Liu Wan-li, et al.
Published: (2010-09-01) -
Autoantibodies against tumor‐associated antigens combined with microRNAs in detecting esophageal squamous cell carcinoma
by: Guiying Sun, et al.
Published: (2020-02-01) -
Anti-CDC25B autoantibody predicts poor prognosis in patients with advanced esophageal squamous cell carcinoma
by: Dong Jun, et al.
Published: (2010-09-01)